Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D002555:Cerebrospinal Fluid / Q000378:metabolism*; D002746:Chlorpromazine / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D003641:Deamination; D003653:Decarboxylation; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000378:metabolism*; D004298:Dopamine / Q000097:blood / Q000378:metabolism; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid / Q000378:metabolism* / Q000502:physiology; D007275:Injections, Intravenous; D008297:Male; D008745:Methylation; D009474:Neurons / Q000378:metabolism; D010648:Phenylacetates / Q000378:metabolism*; D011339:Probenecid / Q000494:pharmacology; D011817:Rabbits; D013268:Stimulation, Chemical; D013997:Time Factors; D014316:Tritium
D010648:Phenylacetates; D014316:Tritium; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D011339:Probenecid; D002746:Chlorpromazine; D004298:Dopamine; D006719:Homovanillic Acid